{"id":"antibiotics-cefuroxime-and-metronidazole","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Hypersensitivity reactions (cefuroxime)"},{"rate":null,"effect":"Metallic taste (metronidazole)"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cefuroxime is a second-generation cephalosporin that binds penicillin-binding proteins and inhibits peptidoglycan cross-linking in bacterial cell walls, leading to cell lysis. Metronidazole is a nitroimidazole that generates reactive intermediates in anaerobic organisms, causing DNA strand breaks and cell death. This combination targets both aerobic gram-negative and gram-positive bacteria as well as anaerobes, commonly used for surgical prophylaxis and mixed infections.","oneSentence":"Cefuroxime inhibits bacterial cell wall synthesis while metronidazole disrupts anaerobic bacterial DNA, together providing broad-spectrum coverage against aerobic and anaerobic pathogens.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:17:21.290Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Surgical site infection prophylaxis"},{"name":"Mixed aerobic-anaerobic bacterial infections"},{"name":"Intra-abdominal infections"},{"name":"Gynecological infections"}]},"trialDetails":[{"nctId":"NCT05784311","phase":"PHASE4","title":"Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2023-03-06","conditions":"Pancreatic Cancer","enrollment":344},{"nctId":"NCT04803422","phase":"NA","title":"Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2021-04-01","conditions":"Complicated Appendicitis","enrollment":3193},{"nctId":"NCT04755179","phase":"","title":"Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population","status":"COMPLETED","sponsor":"Ramon Gorter","startDate":"2019-08-12","conditions":"Appendicitis, Appendix Mass, Appendicitis Perforated","enrollment":1308},{"nctId":"NCT04378868","phase":"PHASE4","title":"Role of Delay and Antibiotics on Perforation Rate While Waiting Appendectomy","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2020-05-18","conditions":"Appendicitis","enrollment":1800},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":"Appendicitis","enrollment":1552},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02916134","phase":"NA","title":"Conservative Versus Operative ManageMent of Acute Uncomplicated Appendicitis","status":"COMPLETED","sponsor":"Beaumont Hospital","startDate":"2016-09-12","conditions":"Appendicitis","enrollment":186},{"nctId":"NCT02505581","phase":"PHASE4","title":"Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis","status":"COMPLETED","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2015-05","conditions":"Surgical Wound Infection","enrollment":536},{"nctId":"NCT04009772","phase":"PHASE2, PHASE3","title":"Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-07-01","conditions":"Emergency Cesarean Section, Infection Wound","enrollment":500},{"nctId":"NCT01283815","phase":"PHASE2","title":"Laparoscopic Management of Periappendicular Abscess","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2011-01","conditions":"Appendicitis, Abdominal Abscess","enrollment":60},{"nctId":"NCT01524081","phase":"PHASE3","title":"Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures","status":"COMPLETED","sponsor":"The Faculty Hospital Na Bulovce","startDate":"2008-07","conditions":"Acute Appendicitis, Perforated Gastroduodenal Ulcer, Small Bowel Obstruction","enrollment":187},{"nctId":"NCT00557453","phase":"","title":"The Role of Antibiotic Treatment in Patients With Acute Mild Cholecystitis - A Prospective Randomized Controlled Trial","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2008-04","conditions":"Acute Cholecystitits","enrollment":120},{"nctId":"NCT00355602","phase":"NA","title":"Antibiotics for the Treatment of Ulcerative Colitis","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2006-07","conditions":"Colitis, Ulcerative","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Antibiotics, cefuroxime and metronidazole","genericName":"Antibiotics, cefuroxime and metronidazole","companyName":"Helsinki University Central Hospital","companyId":"helsinki-university-central-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cefuroxime inhibits bacterial cell wall synthesis while metronidazole disrupts anaerobic bacterial DNA, together providing broad-spectrum coverage against aerobic and anaerobic pathogens. Used for Surgical site infection prophylaxis, Mixed aerobic-anaerobic bacterial infections, Intra-abdominal infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}